The Coalition Against Counterfeit Pharmaceutical products (CACCP), Nigerian Representatives of Overseas Pharmaceutical Manufacturers (NiroPharm) and Pfizer are looking to work together with relevant stakeholders in the pharmaceutical industry in the fight against counterfeit pharmaceutical products in Nigeria. The initiative was presented at its inaugural forum where the way forward in the fight against pharmaceutical products was discussed.
West Africa Country Manager for Pfizer, Mr Olayinka Subair, said that, “Counterfeit medicines don’t cure any disease, rather they put patients’ health at risk because of their contents”, with Femi Soremekun, President of NiroPharm adding that “It is like a race against time for pharmaceutical companies – the cost to our collective health and economies is enormous”.
Convener, Yomi Badejo-Okusanya, said the decision to form the coalition arose as a result of the desire to take a stronger stand against counterfeit pharmaceutical products in Nigeria through engagement and advocacy, with a hope to kick off an intense national advocacy campaign against counterfeit pharmaceutical products.
Source: Coalition Seeks Collaboration against Counterfeit Pharmaceutical Products – THISDAYLIVE
Stakeholders Form Coalition Against Counterfeit Pharmaceutical Products | Business Post Nigeria
